Market Analysis
Frost & Sullivan analysis finds clinical, cost benefits to grow point of care test market
Published in Biotech Business Week, October 9th, 2006
Moreover, POCT fits in with the way people envisage the delivery of future healthcare, one that promotes enhanced quality of care and encourages patients to be more involved in their own disease management. The report, titled "European Point of Care Testing Market," finds that the European POCT market earned revenues of US$754.4 million in 2005 and estimates this to reach US$1558.2 million in 2012.
"POCT can...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Business Update
Clinical Data, others publish results of U.S. FDA-led assessment of microarray gene expression data - Market Analysis
Antidiabetic glitazar market uncertain after five companies cease development, report finds - Market Analysis
Eli Lilly CEO said biomedical breakthroughs are transforming medicine, promise to ease aging - Market Analysis
Neuropathic pain market forecast to grow to $5.5 billion by 2015, market research finds - Accreditation
URAC releases guidelines to gauge consumer protection efforts of healthcare organizations - Acute Bacterial Sinusitis
Oscient announces results of advisory committee meeting for Factive for acute bacterial sinusitis - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
